Glow Peptides · Research Journal
BPC-157 Certificate of Analysis: Verify a Research Lot
Glow Peptides Research Team · 2026-09-17
For research use only. Not for human or veterinary use, diagnostic use, or in any therapeutic application.
A certificate of analysis for BPC-157 is only useful if it describes the vial you are actually holding. Most documents circulating under that name do not: they carry no lot number, or a lot number that is not on your label, or a laboratory that is described rather than named. This guide sets out what a BPC-157 certificate has to contain, how to match a specific vial to its own record field by field, and where the document stops being evidence. Every lot cited below opens a published record you can check for yourself in the COA directory.
If you want the field-by-field reading of the document layout itself, the shorter guide on how to read a peptide certificate of analysis walks it top to bottom, and the per-compound index of published lot records covers finding the right document for any material in the catalog. This page is narrower: one compound, one label, and the specific checks that connect them.
The question a BPC-157 certificate is supposed to answer
BPC-157 is listed by more suppliers than almost any other research peptide, which is precisely why the paperwork matters here. The question a certificate exists to close is narrow. It is not "is this a real compound" and it is not "does this supplier run analysis". It is: what did a laboratory measure, on the batch this vial came from, by what method, and when?
Four answers close that question. Anything else on the page is context rather than evidence, and a document leaving any one of the four open has not done its job, however thorough it looks.
| Field | What it settles | What its absence means |
|---|---|---|
| Lot number | Which batch the document describes | The document is about some other material, or about nothing in particular |
| Identity result | That the material is BPC-157 and not something else of similar purity | A very pure sample of the wrong peptide passes a purity test perfectly |
| Purity result, with the method stated | How much of the detected material is the target compound | A percentage with no method behind it cannot be compared, reproduced or challenged |
| Named laboratory and report date | Who measured it and when | The independence cannot be checked, and the analysis cannot be placed relative to the batch |
Two instruments produce the first two of those results, and they are not interchangeable. Reverse-phase HPLC answers how much of this is the target compound, by separating components in a solvent gradient and reporting the target peak's area against total detected peak area. Mass spectrometry answers is this the right compound at all, by comparing observed mass-to-charge against the mass computed from the sequence. Both methods are explained at length in the guide on HPLC and mass spectrometry.
Matching the vial to the document
The single most common failure is not a fabricated certificate. It is a real certificate for a different batch, accepted because nobody compared the strings. Matching is mechanical work, and it takes about a minute.
Three things have to agree: the lot number printed on the vial label, the lot number on the certificate, and the lot number in the published record you reached independently of the seller. Two out of three is a discrepancy, not a rounding error. If the first two agree but the record cannot be opened without asking, you have verified the seller's copy of their own claim — a weaker result than it feels like.
Read the string exactly as printed
Lot numbers in this catalog are structured rather than random, and punctuation varies between production runs. Two released BPC-157 lots illustrate the point: 260202QLBC10 is written unbroken, while 260406-HP-BC10-4 carries hyphens and a trailing sequence number. Both are well-formed. Neither is a typo of the other.
That variation is the commonest transcription trap. When a search returns nothing, the usual cause is a character misread from a small label — 0 against O, 1 against I — or hyphens added from memory rather than copied from the vial. Re-read the label before concluding anything about the supplier.
Understand the grammar, then stop trusting it
The structure is worth learning for one reason only: so you can tell a lot number from a product code and notice when you have been handed the latter. It is not a verification method. Anyone can print a string that follows a convention.
| Element | In 260202QLBC10 | In 260406-HP-BC10-4 | What it identifies |
|---|---|---|---|
| Date element | 260202 | 260406 | A six-digit YYMMDD date attached to the run |
| Source code | QL | HP | A short code for the production source; QL, HP, ZJ and SXH appear across the catalog |
| Catalog code | BC10 | BC10 | The material and its vial content — BC for BPC-157, 10 for 10 mg total peptide content |
| Sequence number | not present | 4 | Distinguishes runs made close together; present on some lots, not on others |
The catalog code is the part most worth recognising, because it appears on the vial as well as in the lot string and gives you a second independent check. It is a two-letter compound abbreviation followed by the total peptide content in milligrams: BC10 is BPC-157 at 10 mg, TB10 is TB-500 at 10 mg, KP10 is KPV at 10 mg. A -C suffix marks the capsule format of the same material rather than a vial.
One clarification belongs here and applies everywhere a milligram figure appears in this article. The 10 mg in BC10 is the total peptide content of the vial — a specification of what the sealed vial contains as analysed. It is not a quantity of anything to be used, and it does not correspond to any period of time. It exists on the certificate for the same reason a lot number does: so the document can be tied to one specific physical object.
Check the code against the material name
A label that says BPC-157 and carries a catalog code for a different compound is an internal contradiction, and it is one of the few checks you can run on the label alone, before any document is involved. The same applies to the content figure.
Name variants are worth noting because they cause false alarms rather than real ones. The same material is listed across the industry as BPC-157, BPC 157 and BPC157. Hyphenation and spacing are not material differences. What matters is whether the identity result confirms the compound, not how the name was typeset.
Two published BPC-157 lots, worked through
The checks above are easier to trust when you can run them against something real. Both lots below are released, both carry published certificates, and both open without an account, an email address or a request.
| Lot | Catalog code | Material | Record |
|---|---|---|---|
| 260202QLBC10 | BC10 | BPC-157, 10 mg total peptide content | View certificate |
| 260406-HP-BC10-4 | BC10 | BPC-157, 10 mg total peptide content | View certificate |
Open either one and run the sequence: find the lot number, confirm it is the string on your label rather than a similar one, read the laboratory's name, check that the method is stated beside the purity result, and check the report date against the batch. The two lots share a catalog code and a material page, and they are still two different batches with two different records — the entire argument for per-lot publishing, in one example.
When one certificate covers a combination
BPC-157 is also sold as part of combination material, and this is where certificate reading most often goes wrong. Lot 260410HPWV20, catalog code WV20, is a BPC-157 and TB-500 combination at 20 mg total peptide content per vial, and its record is published at /coa/ee662738-2ae4-4891-9dde-b65e36291331.
Two things about that document are worth stating precisely, because both are commonly misread.
The milligram figure is the total across the vial. Twenty milligrams on a two-component vial is the combined peptide content, not the content of either component individually, and certainly not a quantity of anything. A reader who assumes the headline figure applies to each component separately has doubled the material in their head. The comparison of the two compounds as research materials sits in the guide on BPC-157 and TB-500.
Purity on a combination is per component. A blend is not one compound, so a single purity figure for the vial as a whole would not mean anything — the two components would register as two separate peaks, and each peak's area is the purity statement for that component. The published specification of ≥99.2% is a floor that applies per component rather than to the mixture. Identity is likewise confirmed per component: the mass of each has to be found, not just the mass of one.
So checking a combination lot means verifying two sets of results on one document. A certificate reporting a single purity number with no indication of which component it belongs to has not told you what you need, whatever the number is.
What the purity figure on a BPC-157 certificate does not say
Purity is the number everybody reads first and the number most often over-read. Four limits apply, and stating them is not a hedge — it is what the measurement actually is.
It is a floor, not a typical value. The published specification is ≥99.2%, which means it is the number every released lot has to clear rather than a number some lots reach. An average tolerates lots below it by definition; a floor does not. When comparing two suppliers, establish what kind of statement each figure is before comparing the digits.
It is method-dependent. A purity result is a percentage under one HPLC method — column chemistry, gradient, detection wavelength, run length. Change any of them and the number moves without the material changing at all. Two figures produced under undisclosed methods are not comparable, which is why the method belongs on the page next to the result.
It describes what the detector could see. A figure of ≥99.2% under a stated method means no more than 0.8% of detected material was anything other than the target peak. Species the detector does not respond to are not in that calculation. This is a genuine limit of the technique rather than a criticism of it, and it is exactly why identity confirmation by mass is not optional.
It is an area percentage, not a weight. Chromatographic purity describes the proportion of detected peak area attributable to the target compound. It is a different quantity from the proportion of a vial's contents by mass that is peptide, and the two should not be read as the same statement. A certificate reporting chromatographic purity is answering the first question. What a purity percentage leaves out is covered in full in how research peptide purity is verified.
Why identity is the check people skip
Almost everyone reading a BPC-157 certificate goes straight to the purity figure. The identity result is the one that decides whether the purity figure is about the right compound at all.
The failure mode is specific. A sample of an entirely different peptide, well purified, produces a clean single peak and an excellent HPLC percentage. Nothing in the chromatogram says which compound the peak is. Only the mass measurement establishes that the peak belongs to BPC-157 rather than to a shorter sequence, a related analogue or an unrelated material that happens to elute similarly.
Read the document in that order: identity first, purity second. A certificate with a strong purity figure and no identity result has confirmed that something is very pure.
What the document cannot establish
A lot certificate is the strongest routine evidence available for research material, and it is still a bounded claim. Stating the boundaries in the same breath as the strengths is the difference between a record and a sales document.
- It describes one batch. Synthesis, cleavage and purification are repeated per run, and the impurity profile belongs to the run. The certificate for 260202QLBC10 says nothing about 260406-HP-BC10-4, and neither says anything about a future lot.
- It is time-stamped. The analysis reflects the material on the date it was tested. The document is a record of a measurement, not a warranty extending forward in time.
- It does not cover what happened after testing. Storage conditions — temperature, light exposure, whether the vial stayed sealed — sit outside what any certificate from any supplier can speak to.
- It reports the attributes that were in that report. Where a lot's report includes an additional attribute such as endotoxin, the result appears on that lot's certificate and applies to that lot. Absence means the attribute was not part of that report, not that anything failed.
- It speaks only to composition. A certificate is an analytical document. It establishes what was measured and nothing wider.
Red flags on a BPC-157 certificate
These are the patterns worth refusing, roughly in order of seriousness. They apply to any supplier, and BPC-157 attracts more of them than most materials simply because more of it is listed.
- No lot number, or one that is not on your vial. Nothing else on the document applies to the material you have. This is not a technicality; it is the whole question.
- One document offered for every BPC-157 order. Certificates describe batches. A document that never changes is describing a batch that may no longer exist.
- The laboratory is described rather than named. "An accredited independent lab" is not a laboratory you can look up, and an independence claim you cannot check is doing the work of no claim at all.
- A purity figure with no stated method. Not comparable, not reproducible, not challengeable — a marketing number wearing an analytical format.
- A purity figure quoted as typical or average. An average is a statement that some lots sit below it. Compare the kind of claim before the digits.
- Round or perfect numbers. Real chromatography produces uneven figures, rarely round ones. A column of even values suggests numbers written rather than measured.
- No identity result at all. Purity without identity confirms that something was pure.
- A single purity figure on a combination vial. Two components need two results, each attributable to a named component.
- Documentation only on request. Verification that depends on the seller's cooperation is not independent verification, and the dependency bites at exactly the moment you have a question.
- A report date that does not belong to the batch. Dated before the batch existed, or long after it was made, the document is describing something else.
A check you can run before ordering
None of this requires specialist knowledge, and most of it can be done on a supplier's site before ordering. The attempt itself is the finding.
- Find a specific BPC-157 lot on the supplier's site. Not a product page claiming certificates exist — a named lot.
- Open its certificate without giving an email address. If a form stands between you and the document, verification is inside the seller's control.
- Read the laboratory's name. Named and contactable is checkable. Described is not.
- Confirm both results are present. An identity result and a purity result, with the method stated beside the purity figure.
- Repeat on a second lot of the same material. Two lots should produce two different documents. If the same document appears twice, the supplier documents products rather than batches.
When the vial arrives, run the match: the lot on the label against the lot on the certificate against the lot in the published record. A supplier who makes that easy has built for it. A supplier who makes it a conversation has answered the question a different way.
How this works here
Every released lot is analysed by an independent laboratory — Freedom Diagnostics, named on the certificates themselves — using reverse-phase HPLC for purity and mass spectrometry for identity. The published specification is a floor of ≥99.2%, the number every released lot has to clear, and on combination material it applies per component.
The records are public per lot. The COA directory lists them, the QR code on a vial opens the record for that vial's own lot, and the BPC-157 material page links the lots published for it. There is no account, no request and no support conversation in any of those routes, which is deliberate: a record you can open without asking is a record that existed before you asked. The wider catalog works the same way, and the per-compound index lists published lots for the rest of the materials.
Two limits belong in the same paragraph as those claims, for the reason this article has been making throughout. Analytical results are specific to the lot and to the method used. And a certificate describes material as analysed on a date — it does not extend forward through storage and handling, and no certificate from any supplier can. The broader argument about what independent analysis does and does not establish is in third-party testing and independent verification.
Frequently asked questions
What should a BPC-157 certificate of analysis contain?
Four things carry the weight: a lot number matching the vial, an identity result confirming the compound by mass spectrometry, a purity result by reverse-phase HPLC with the method stated beside it, and a named laboratory with a report date. Anything else is context. A document missing any one of the four has left open a question it exists to close — most commonly the identity result, which is the field readers skip and the one that decides whether the purity figure describes the right compound.
How do I check that a BPC-157 COA matches my vial?
Compare three strings: the lot number printed on the label, the lot number on the certificate, and the lot number in a published record you reached without asking the seller. All three must be identical, character for character, including hyphens. Real lots differ in punctuation — 260202QLBC10 is unbroken while 260406-HP-BC10-4 is hyphenated — so copy from the label rather than from memory. Two matching out of three is a discrepancy worth resolving before anything else on the document matters.
What does BC10 mean on a BPC-157 label?
It is the catalog code: a two-letter compound abbreviation followed by the total peptide content of the vial in milligrams. BC10 is BPC-157 at 10 mg, the same way TB10 is TB-500 at 10 mg and KP10 is KPV at 10 mg. A -C suffix marks the capsule format of the same material. The code also appears inside the lot number, which gives you a second check: a vial whose printed material name and catalog code disagree is an internal contradiction you can spot before opening any document.
Does a BPC-157 and TB-500 combination lot need two certificates?
No — one certificate covers the lot, but it has to report results per component. A combination vial contains two compounds, so a single purity figure for the vial as a whole would not mean anything: each component registers as its own peak, and each peak's area is that component's purity statement. Identity works the same way, with the mass of each component confirmed separately. The published floor of ≥99.2% applies per component. A combination certificate quoting one unattributed number has not answered the question.
Can I see a BPC-157 COA before ordering?
You should be able to, and whether you can is itself informative. Published per-lot records let you open a specific lot's certificate before you order and check the same record again after the vial arrives, with no account and no request. Two released BPC-157 lots are published now, 260202QLBC10 and 260406-HP-BC10-4, each with its own document. Documentation that exists only on request places verification inside the seller's control at exactly the point independence matters most.